Nanalysis Scientific Corp.
NSCIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3% | -9.6% | -13.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 21.9% | 24.3% | 25.6% | 34.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3.8% | -8.2% | -0% | -49.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -16.2% | -22.2% | -12.3% | -60.6% |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.066 |
| % Growth | 50% | -100% | 84.8% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |